Not all zombie skin cells are the same. New research reveals three unique subtypes with different roles in aging and disease, ...

CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...